Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20528157 | 0.97 | LMNA (0.33) | LMNA | |
| SCHEMBL1978019 | 0.94 | LMNA (0.42) | LMNATHRB | |
| SCHEMBL8105478 | 0.94 | LMNA (0.42) | LMNATHRB | |
| SCHEMBL575320 | 0.90 | LMNA (0.37) | LMNATHRB | |
| SCHEMBL576835 | 0.79 | LMNA (0.32) | LMNA | |
| SCHEMBL576936 | 0.79 | — | — | |
| SCHEMBL3833946 | 0.71 | LMNA (0.40) | LMNATHRB | |
| Perflexane SCHEMBL20769778 | 0.71 | LMNA (0.61) | LMNATHRB | |
| SCHEMBL771546 | 0.71 | LMNA (0.61) | LMNATHRB | |
| SCHEMBL984715 | 0.71 | LMNA (0.61) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10399916-B2 | Method of producing hydrofluoroolefin | AGC Inc. (JP) | 2019-09-03 | — | — | US | disclosed |
| EP-3392229-A1 | METHOD FOR PRODUCING HYDROFLUOROOLEFIN | AGC Inc. (JP) | 2018-10-24 | — | — | EP | disclosed |
| US-20180290951-A1 | METHOD OF PRODUCING HYDROFLUOROOLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2018-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10399916-B2 | Method of producing hydrofluoroolefin | HAO2, SFXN1, HAX1 | LMNA 2929/4885THRB 2184/4885 |
| US-20180290951-A1 | METHOD OF PRODUCING HYDROFLUOROOLEFIN | HAO2, SFXN1, HAX1 | LMNA 2929/4885THRB 2184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.